Heska (HSKA) LT-Debt-to-Total-Asset : 0.18 (As of Mar. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Heska LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Heska's long-term debt to total assests ratio for the quarter that ended in Mar. 2023 was 0.18.

Heska's long-term debt to total assets ratio increased from Mar. 2022 (0.18) to Mar. 2023 (0.18). It may suggest that Heska is progressively becoming more dependent on debt to grow their business.

Heska LT-Debt-to-Total-Asset Historical Data

The historical data trend for Heska's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heska LT-Debt-to-Total-Asset Chart

Heska Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.04

0.21

0.13

0.17

Heska Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.18	0.18	0.18	0.17	0.18

Heska LT-Debt-to-Total-Asset Calculation

Heska's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )	/	Total Assets (A: Dec. 2022 )
	=	100.125	/	585.816
	=	0.17

Heska's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (Q: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2023 )	/	Total Assets (Q: Mar. 2023 )
	=	105.383	/	592.715
	=	0.18

Heska (NAS:HSKA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Heska LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Heska's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Heska (HSKA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heska Corp (NAS:HSKA) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

AHCO SILK AVNS UFPT FNA PRCT SIBN CTKB OM TMCI ABT MDT SYK BSX EW SZSE:300760 DXCM ZBH ALGN STE

Traded in Other Exchanges

N/A

Address

3760 Rocky Mountain Avenue, Loveland, CO, USA, 80538

Website

https://www.heska.com

Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments.

Executives

Joachim A. Hasenmaier	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Robert L Antin	director
Mark F Furlong	director	770 M WATER ST, MILWAUKEE WI 53202
Stephen L Davis	director	2901 BUTTERFIELD ROAD, OAK BROOK IL 60523
Providenti Anthony C. Jr.	officer: EVP, Corporate Development	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Kevin S. Wilson	officer: President and COO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Eleanor F. Baker	officer: EVP, Managing Dir. & COO, scil	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Christopher D. Sveen	officer: CAO & General Counsel	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Nancy Wisnewski	officer: EVP, Prod. Dev. & Cust. Supp	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Sharon L. Riley	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Catherine Grassman	officer: EVP, CFO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason D Aroesty	officer: EVP, International Diagnostics	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Bonnie J. Trowbridge	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Scott Humphrey	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason A Napolitano	officer: Exec. VP, CFO & Secretary	1613 PROSPECT PARKWAY, FORT COLLINS CO 80525